|
1
|
Jane JA Jr and Laws ER Jr: The surgical
management of pituitary adenomas in a series of 3,093 patients. J
Am Coll Surg. 193:651–659. 2001.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bahuleyan B, Raghuram L, Rajshekhar V and
Chacko AG: To assess the ability of MRI to predict consistency of
pituitary macroadenomas. Br J Neurosurg. 20:324–326.
2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Iuchi T, Saeki N, Tanaka M, Sunami K and
Yamaura A: MRI prediction of fibrous pituitary adenomas. Acta
Neurochir (Wien). 140:779–786. 1998.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mahmoud OM, Tominaga A, Amatya VJ, Ohtaki
M, Sugiyama K, Sakoguchi T, Kinoshita Y, Takeshima Y, Abe N,
Akiyama Y, et al: Role of PROPELLER diffusion-weighted imaging and
apparent diffusion coefficient in the evaluation of pituitary
adenomas. Eur J Radiol. 80:412–417. 2011.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pierallini A, Caramia F, Falcone C,
Tinelli E, Paonessa A, Ciddio AB, Fiorelli M, Bianco F, Natalizi S,
Ferrante L and Bozzao L: Pituitary macroadenomas: Preoperative
evaluation of consistency with diffusion-weighted MR
imaging-initial experience. Radiology. 239:223–231. 2006.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Sen A, Das C, Mukhopadhyay M, Mukhopadhyay
S, Deb S and Mukhopadhyay B: Cytohistological correlation in
pituitary tumor and immunological assessment with the help of
Ki-67. J Postgrad Med. 63:96–99. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bidari-Zerehpoosh F, Sharifi G, Novin K
and Mortazavi N: Invasive growth hormone producing pituitary
adenoma with lymphocytic infiltration: A case report and literature
review. Iran J Cancer Prev. 8(e3504)2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jin G, Hao S, Xie J, Mi R and Liu F:
Collision tumors of the sella: Coexistence of pituitary adenoma and
craniopharyngioma in the sellar region. World J Surg Oncol.
11(178)2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mete O and Lopes MB: Overview of the 2017
WHO classification of pituitary tumors. Endocr Pathol. 28:228–243.
2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lopes MB: Growth hormone-secreting
adenomas: Pathology and cell biology. Neurosurg Focus.
29(E2)2010.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Molitch ME: Diagnosis and treatment of
pituitary adenomas: A review. JAMA. 317:516–524. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Theodros D, Patel M, Ruzevick J, Lim M and
Bettegowda C: Pituitary adenomas: Historical perspective, surgical
management and future directions. CNS Oncol. 4:411–429.
2015.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dai C, Liu X, Ma W and Wang R: The
treatment of refractory pituitary adenomas. Front Endocrinol
(Lausanne). 10(334)2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang
J, Ma WB, Yang Y and Wang RZ: Extended transsphenoidal approach for
pituitary adenomas invading the anterior cranial base, cavernous
sinus, and clivus: A single-center experience with 126 consecutive
cases. J Neurosurg. 112:108–117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Han ZL, He DS, Mao ZG and Wang HJ:
Cerebrospinal fluid rhinorrhea following trans-sphenoidal pituitary
macroadenoma surgery: Experience from 592 patients. Clin Neurol
Neurosurg. 110:570–579. 2008.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wei L, Lin SA, Fan K, Xiao D, Hong J and
Wang S: Relationship between pituitary adenoma texture and collagen
content revealed by comparative study of MRI and pathology
analysis. Int J Clin Exp Med. 8:12898–12905. 2015.PubMed/NCBI
|
|
17
|
Zada G, Yashar P, Robison A, Winer J,
Khalessi A, Mack WJ and Giannotta SL: A proposed grading system for
standardizing tumor consistency of intracranial meningiomas.
Neurosurg Focus. 35(E1)2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shiroishi MS, Cen SY, Tamrazi B, D'Amore
F, Lerner A, King KS, Kim PE, Law M, Hwang DH, Boyko OB and Liu CS:
Predicting meningioma consistency on preoperative neuroimaging
studies. Neurosurg Clin N Am. 27:145–154. 2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tamrazi B, Shiroishi MS and Liu CS:
Advanced imaging of intracranial meningiomas. Neurosurg Clin N Am.
27:137–143. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yao A, Pain M, Balchandani P and
Shrivastava RK: Can MRI predict meningioma consistency?: A
correlation with tumor pathology and systematic review. Neurosurg
Rev. 41:745–753. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Naganuma H, Satoh E and Nukui H: Technical
considerations of transsphenoidal removal of fibrous pituitary
adenomas and evaluation of collagen content and subtype in the
adenomas. Neurol Med Chir (Tokyo). 42:202–213. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hagiwara A, Inoue Y, Wakasa K, Haba T,
Tashiro T and Miyamoto T: Comparison of growth hormone-producing
and non-growth hormone-producing pituitary adenomas: Imaging
characteristics and pathologic correlation. Radiology. 228:533–538.
2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Knosp E, Steiner E, Kitz K and Matula C:
Pituitary adenomas with invasion of the cavernous sinus space: A
magnetic resonance imaging classification compared with surgical
findings. Neurosurgery. 33:610–618. 1993.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wang H, Li W, Shi D, Ye Z, Qin F, Guo Y
and Yuan X: Expression of TGFbeta1 and pituitary adenoma fibrosis.
Br J Neurosurg. 23:293–296. 2009.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yiping L, Ji X, Daoying G and Bo Y:
Prediction of the consistency of pituitary adenoma: A comparative
study on diffusion-weighted imaging and pathological results. J
Neuroradiol. 43:186–194. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ghosh AK: Factors involved in the
regulation of type I collagen gene expression: Implication in
fibrosis. Exp Biol Med (Maywood). 227:301–314. 2002.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kuivaniemi H and Tromp G: Type III
collagen (COL3A1): Gene and protein structure, tissue distribution,
and associated diseases. Gene. 707:151–171. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Fleischmajer R, MacDonald ED, Perlish JS,
Burgeson RE and Fisher LW: Dermal collagen fibrils are hybrids of
type I and type III collagen molecules. J Struct Biol. 105:162–169.
1990.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cameron GJ, Alberts IL, Laing JH and Wess
TJ: Structure of type I and type III heterotypic collagen fibrils:
An X-ray diffraction study. J Struct Biol. 137:15–22.
2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Xu S, Xu H, Wang W, Li S, Li H, Li T,
Zhang W, Yu X and Liu L: The role of collagen in cancer: From bench
to bedside. J Transl Med. 17(309)2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Discher DE, Smith L, Cho S, Colasurdo M,
Garcia AJ and Safran S: Matrix Mechanosensing: From scaling
concepts in ‘Omics data to mechanisms in the nucleus, regeneration,
and cancer. Annu Rev Biophys. 46:295–315. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yamauchi M, Barker TH, Gibbons DL and
Kurie JM: The fibrotic tumor stroma. J Clin Invest. 128:16–25.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Oliveira-Ferrer L, Rößler K, Haustein V,
Schröder C, Wicklein D, Maltseva D, Khaustova N, Samatov T,
Tonevitsky A, Mahner S, et al: c-FOS suppresses ovarian cancer
progression by changing adhesion. Br J Cancer. 110:753–763.
2014.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lambrechts D, Wauters E, Boeckx B, Aibar
S, Nittner D, Burton O, Bassez A, Decaluwé H, Pircher A, Van den
Eynde K, et al: Phenotype molding of stromal cells in the lung
tumor microenvironment. Nat Med. 24:1277–1289. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kuczek DE, Larsen AMH, Thorseth ML,
Carretta M, Kalvisa A, Siersbaek MS, Simões AMC, Roslind A,
Engelholm LH, Noessner E, et al: Collagen density regulates the
activity of tumor-infiltrating T cells. J Immunother Cancer.
7(68)2019.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Suzuki C, Maeda M, Hori K, Kozuka Y,
Sakuma H, Taki W and Takeda K: Apparent diffusion coefficient of
pituitary macroadenoma evaluated with line-scan diffusion-weighted
imaging. J Neuroradiol. 34:228–235. 2007.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Musleh W, Sonabend AM and Lesniak MS: Role
of craniotomy in the management of pituitary adenomas and
sellar/parasellar tumors. Expert Rev Anticancer Ther. 6 (Suppl
9):S79–S83. 2006.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Thotakura AK, Patibandla MR, Panigrahi MK
and Mahadevan A: Is it really possible to predict the consistency
of a pituitary adenoma preoperatively? Neurochirurgie. 63:453–457.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Mastorakos P, Mehta GU, Chatrath A, Moosa
S, Lopes MB, Payne SC and Jane JA Jr: Tumor to cerebellar peduncle
T2-weighted imaging intensity ratio fails to predict pituitary
adenoma consistency. J Neurol Surg B Skull Base. 80:252–257.
2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yamamoto J, Kakeda S, Shimajiri S,
Takahashi M, Watanabe K, Kai Y, Moriya J, Korogi Y and Nishizawa S:
Tumor consistency of pituitary macroadenomas: Predictive analysis
on the basis of imaging features with contrast-enhanced 3D FIESTA
at 3T. AJNR Am J Neuroradiol. 35:297–303. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yao A, Rutland JW, Verma G, Banihashemi A,
Padormo F, Tsankova NM, Delman BN, Shrivastava RK and Balchandani
P: Pituitary adenoma consistency: Direct correlation of ultrahigh
field 7T MRI with histopathological analysis. Eur J Radiol.
126(108931)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Koktekir E, Karabagli H and Ozturk K:
Simultaneous transsphenoidal and transventricular endoscopic
approaches for giant pituitary adenoma with hydrocephalus. J
Craniofac Surg. 26:e39–e42. 2015.PubMed/NCBI View Article : Google Scholar
|
